Home / Biosimilars

Biosimilars

News

Indications expanded for Merck’s etanercept biosimilar Brenzys posted 28/09/2020

The indications of Merck Canada’s etanercept biosimilar Brenzys have been expanded to include plaque psoriasis, psoriatic art...

Insulin glargine biosimilar Semglee launched in US posted 28/09/2020

The partnership of US-based drugmaker Mylan and Indian biologicals specialist Biocon announced on 31 August 2020 the lau...

16704526_l Daewon launches teriparatide biosimilar in South Korea posted 28/09/2020

South Korea-based Daewon Pharmaceutical (Daewon) announced that it has launched the teriparatide biosimilar Terrosa.

Cadila Pharmaceuticals launches two similar biologics in India posted 28/09/2020

Indian generics maker Cadila Pharmaceuticals Ltd (Cadila) has launched two new similar biologics in the country: Bevaro (beva...

Turkey 2016 COVER V16E31DG Samsung Bioepis launches Ontruzant in Brazil posted 28/09/2020

South Korean biotechnology company Samsung Bioepis has announced the launch of their trastuzumab biosimilar Ontruzant in Braz...

 

Research

EU MedSoc 2016 Cover V15L30DG Sustainable biosimilar policies in Europe posted 28/09/2020

A review of approaches to biosimilar policy in Europe [1] highlights key principles for a sustainable biosimilar market, incl...

Biosimilar infliximab reduces medication costs by two thirds in Finland posted 28/09/2020

A study of 54 people with inflammatory bowel disease (IBD) in Finland showed that switching to biosimilar infliximab has no s...

Trastuzumab biosimilar Kanjinti is stable over extended storage periods posted 28/09/2020

An investigation of the quality and in-use stability of diluted trastuzumab biosimilar Kanjinti (also known as ABP 980) versu...

Quotas improve biosimilar use in Germany posted 28/09/2020

An assessment of the role of cost control measures on biological drugs in Germany finds that quotas for biosimilars are in so...

Denmark achieves 83% reduction in adalimumab costs through switching posted 28/09/2020

Spending on adalimumab in Denmark decreased by almost 83% between September and December 2018, thanks to a mandatory switchin...

 

General

FDA updates Purple Book database posted 28/09/2020

The US Food and Drug Administration (FDA) has updated its searchable Purple Book database to include allergenic, cellular and...

Country scorecards show biosimilar sustainability posted 28/09/2020

Biosimilars are an important component of sustainable health systems as they provide alternatives to originator biological pr...

Duopharma to establish Malaysia’s first commercial biosimilar facility posted 28/09/2020

Malaysia-based manufacturer Duopharma Biotech aims to establish Malaysia’s first commercial biosimilar production facility. T...

WHO prequalifies Celltrion’s trastuzumab biosimilar Herzuma posted 28/09/2020

The World Health Organization (WHO) has prequalified Celltrion Healthcare’s second biosimilar, a trastuzumab biosimilar sold...

Clinical trials for trastuzumab biosimilars posted 28/09/2020

Roche’s originator trastuzumab biological (Herceptin) was approved by the US Food and Drug Administration (FDA) in September...